Published in Science on October 05, 1973
A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J (1991) 3.83
Isolation of peroxisome-deficient mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1989) 2.80
Peroxisomal bifunctional enzyme deficiency. J Clin Invest (1989) 2.11
Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci U S A (1987) 1.98
Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A (1984) 1.75
Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. J Clin Invest (1988) 1.68
A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet (1988) 1.59
Phospholipid transfer proteins revisited. Biochem J (1997) 1.49
Differential protein import deficiencies in human peroxisome assembly disorders. J Cell Biol (1994) 1.47
Bile acid metabolism and signaling. Compr Physiol (2013) 1.42
The peroxisome: still a mysterious organelle. Histochem Cell Biol (2008) 1.41
Isolation of animal cell mutants deficient in plasmalogen biosynthesis and peroxisome assembly. Proc Natl Acad Sci U S A (1986) 1.41
A complex containing two transcription factors regulates peroxisome proliferation and the coordinate induction of beta-oxidation enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.40
An efficient screen for peroxisome-deficient mutants of Pichia pastoris. J Bacteriol (1992) 1.37
Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. Proc Natl Acad Sci U S A (1991) 1.37
Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol (2004) 1.35
Biosynthesis and maturation of peroxisomal beta-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci U S A (1986) 1.31
Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res (2010) 1.30
PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol Cell Biol (2002) 1.28
Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol (2001) 1.17
Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat--store 'em up or burn 'em down. Genetics (2013) 1.13
Novel peroxisome clustering mutants and peroxisome biogenesis mutants of Saccharomyces cerevisiae. J Cell Biol (1993) 1.11
Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders. J Clin Invest (1993) 1.10
Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J Clin Invest (1992) 1.08
Peroxisomal organization in normal and cerebrohepatorenal (Zellweger) syndrome fibroblasts. Proc Natl Acad Sci U S A (1985) 1.06
Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes (2012) 1.05
Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders. J Cell Biol (1985) 1.04
Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol (1997) 1.02
Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. J Clin Invest (1994) 0.99
Structure and lipid distribution of polyenoic very-long-chain fatty acids in the brain of peroxisome-deficient patients (Zellweger syndrome). Biochem J (1987) 0.99
Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation. J Clin Invest (1990) 0.98
Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. J Clin Invest (1993) 0.98
Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol Cell Biol (2003) 0.95
Metabolism of saturated and polyunsaturated fatty acids by normal and Zellweger syndrome skin fibroblasts. Biochem J (1989) 0.95
Neonatal adrenoleukodystrophy. J Neurol Neurosurg Psychiatry (1986) 0.94
Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome). Proc Natl Acad Sci U S A (1986) 0.93
Bile acids: the role of peroxisomes. J Lipid Res (2009) 0.93
Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol (2015) 0.93
Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis. Proc Natl Acad Sci U S A (2010) 0.92
The role of peroxisomes in mammalian cellular metabolism. J Inherit Metab Dis (1987) 0.92
Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells. J Inherit Metab Dis (1987) 0.91
Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger. J Clin Invest (1985) 0.91
Zellweger syndrome and associated phenotypes. J Med Genet (1996) 0.90
Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol Cell Biol (2003) 0.90
Intracellular traffic of newly synthesized proteins. Current understanding and future prospects. J Clin Invest (1989) 0.89
Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT). Fetal Pediatr Pathol (2014) 0.89
Peroxisome-mitochondria interplay and disease. J Inherit Metab Dis (2015) 0.88
Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J Inherit Metab Dis (1989) 0.87
Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis (2015) 0.87
Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. Environ Health Perspect (1999) 0.87
Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders. J Inherit Metab Dis (2001) 0.87
In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid. J Clin Invest (1985) 0.86
Cerebral malformation associated with metabolic disorder. A report of 2 cases. Acta Neuropathol (1976) 0.86
Cerebral abnormalities in thanatophoric dysplasia. Childs Nerv Syst (1991) 0.85
Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Proc Natl Acad Sci U S A (1987) 0.85
Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata. J Lipid Res (2012) 0.83
The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Mol Genet Metab (2014) 0.83
Peroxisomal localization of glucose-6-phosphate dehydrogenase and pyrophosphate-stimulated dihydroxyacetone-phosphate acyltransferase in mouse kidney. Biochem J (1987) 0.83
Prenatal and perinatal diagnosis of peroxisomal disorders. J Inherit Metab Dis (1989) 0.82
Clinical approach to inherited peroxisomal disorders. J Inherit Metab Dis (1995) 0.82
Species variation in organellar location and activity of L-pipecolic acid oxidation in mammals. J Comp Physiol B (1991) 0.82
Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. Neurology (2010) 0.82
Tapetoretinal degeneration in the cerebro-hepato-renal (Zellweger's) syndrome. Br J Ophthalmol (1982) 0.82
Zellweger syndrome and secondary mitochondrial myopathy. Eur J Pediatr (2014) 0.81
Peroxisomal disorders: clinical characterization. J Inherit Metab Dis (1987) 0.80
Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans. J Clin Invest (1991) 0.80
High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders. Orphanet J Rare Dis (2014) 0.80
III. Cellular ultrastructures in situ as key to understanding tumor energy metabolism: biological significance of the Warburg effect. F1000Res (2013) 0.79
The Δ4-desaturation pathway for DHA biosynthesis is operative in the human species: differences between normal controls and children with the Zellweger syndrome. Lipids Health Dis (2010) 0.79
Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid. J Clin Invest (1991) 0.79
Immunocytochemical localization of peroxisomal enzymes in human liver biopsies. Am J Pathol (1987) 0.79
Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy. Am J Pathol (1986) 0.79
Inborn errors of cellular organelles: an overview. J Inherit Metab Dis (1987) 0.77
Testicular feminization of the mouse: paucity of peroxisomes in Leydig cell of the testis. Am J Pathol (1981) 0.77
Generalized peroxisomal disorder in male twins: fatty acid composition of serum lipids and response to n-3 fatty acids. J Inherit Metab Dis (1998) 0.77
Peroxisomes are required for lipid metabolism and muscle function in Drosophila melanogaster. PLoS One (2014) 0.77
Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment. J Inherit Metab Dis (1987) 0.77
The significance of hyperpipecolatemia in Zellweger syndrome. Am J Hum Genet (1986) 0.75
Autopsy findings in two siblings with infantile Refsum disease. Acta Neuropathol (1992) 0.75
Teratogenic inborn errors of metabolism. Postgrad Med J (1986) 0.75
Zellweger syndrome: A cause of neonatal hypotonia and seizures. Sudan J Paediatr (2011) 0.75
Purification, properties, and immunocytochemical localization of human liver peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci U S A (1987) 0.75
Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts. J Clin Invest (1993) 0.75
Cell biology: Organelle formation from scratch. Nature (2017) 0.75
Identification of a novel PEX14 mutation in Zellweger syndrome. BMJ Case Rep (2009) 0.75
Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. J Clin Invest (1987) 0.75
Characterization of the binding sites for dicarboxylic acids on bovine serum albumin. Biochem J (1991) 0.75
The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders. J Inherit Metab Dis (2016) 0.75
Peroxisomes and disease - an overview. Int J Biomed Sci (2006) 0.75
Prenatal diagnosis of the cerebro-hepato-renal (Zellweger) syndrome by detection of an impaired plasmalogen biosynthesis. J Inherit Metab Dis (1985) 0.75
Stereoselective analysis of 2-hydroxysebacic acid in urine of patients with Zellweger syndrome and of premature infants fed with medium-chain triglycerides. J Inherit Metab Dis (2003) 0.75
Accurate cleavage and polyadenylation of exogenous RNA substrate. Cell (1985) 5.27
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet (2001) 4.63
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord (1999) 3.77
Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology (2000) 3.70
Site-specific polyadenylation in a cell-free reaction. Cell (1984) 3.59
Specific inhibition of mitochondrial Ca++ transport by ruthenium red. Biochem Biophys Res Commun (1971) 3.53
Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3'-end formation in yeast. Genes Dev (1997) 3.47
Neonatal mortality: an analysis of the recent improvement in the United States. Am J Public Health (1980) 3.20
Visualization of peroxisomes (microbodies) and mitochondria with diaminobenzidine. J Histochem Cytochem (1969) 3.06
Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat Cell Biol (2000) 2.84
The very low-birth-weight rate: Principal predictor of neonatal mortality in industrialized populations. J Pediatr (1980) 2.79
Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol Cell Biol (2000) 2.64
Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol (1966) 2.41
Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost (2008) 2.33
Evidence that Alzheimer neurofibrillary tangles originate from neurotubules. Lancet (1979) 2.22
The cytochemical demonstration of lysosomal aryl sulfatase activity by light and electron microscopy. J Histochem Cytochem (1966) 2.17
Epileptiform EEG abnormalities in children with language regression. Neurology (2005) 2.13
The demonstration of acid hydrolase, thermostable reduced diphosphopyridine nucleotide tetrazolium reductase and peroxidase activities in human lipofuscin pigment granules. J Histochem Cytochem (1966) 2.09
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med (1969) 2.09
Predictors and correlates of adaptive functioning in children with developmental disorders. J Autism Dev Disord (2001) 2.06
Isolation of filaments from brain. Science (1971) 2.03
Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci U S A (1987) 1.98
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest (1970) 1.93
Longitudinal examination of the behavioral, language, and social changes in a population of adolescents and young adults with autistic disorder. Pediatr Neurol (1996) 1.93
Purification of the Saccharomyces cerevisiae cleavage/polyadenylation factor I. Separation into two components that are required for both cleavage and polyadenylation of mRNA 3' ends. J Biol Chem (1996) 1.90
Electrophoretic separation of polyadenylation-specific complexes. Genes Dev (1987) 1.86
EFFECT OF AGE ON THE ENZYME ACTIVITY IN ERYTHROCYTES. Proc Natl Acad Sci U S A (1958) 1.83
Rna15 interaction with the A-rich yeast polyadenylation signal is an essential step in mRNA 3'-end formation. Mol Cell Biol (2001) 1.82
Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer (1968) 1.80
Analysis of RNA cleavage at the adenovirus-2 L3 polyadenylation site. EMBO J (1986) 1.80
The cytoskeleton of primary astrocytes in culture contains actin, glial fibrillary acidic protein, and the fibroblast-type filament protein, vimentin. J Neurochem (1981) 1.79
Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A (1984) 1.75
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes. Diabet Med (1992) 1.73
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol (1991) 1.73
Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol (1990) 1.71
Structure of yeast poly(A) polymerase alone and in complex with 3'-dATP. Science (2000) 1.70
Point mutations upstream of the yeast ADH2 poly(A) site significantly reduce the efficiency of 3'-end formation. Mol Cell Biol (1991) 1.69
Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry (1999) 1.67
Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf) (1998) 1.63
The lipid composition of purified bovine brain myelin. J Neurochem (1966) 1.62
Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics (1970) 1.60
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
Nucleoside diphosphatase and thiamine pyrophosphatase activities in the endoplasmic reticulum and golgi apparatus. J Histochem Cytochem (1971) 1.56
Axons: isolation from mammalian central nervous system. Science (1972) 1.55
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology (2002) 1.54
Patterns of anomalies in children with malformed ears. Laryngoscope (1976) 1.51
Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics (1997) 1.50
Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy. Neurology (1998) 1.48
Ultrastructural immunogold labeling of glial filaments in osmicated and unosmicated epoxy-embedded tissue. J Histochem Cytochem (1990) 1.47
Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.47
Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. Lab Invest (1974) 1.44
Termination and pausing of RNA polymerase II downstream of yeast polyadenylation sites. Mol Cell Biol (1993) 1.43
Brief report: cerebral syphilitic gumma confirmed by the polymerase chain reaction in a man with human immunodeficiency virus infection. N Engl J Med (1994) 1.41
Determinants of the neonatal mortality. Am J Dis Child (1976) 1.41
The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev (1977) 1.40
Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1975) 1.40
Executive functioning in high-functioning children with autism. J Child Psychol Psychiatry (2001) 1.40
Acquired aphasia in children. J Child Neurol (1995) 1.39
Alzheimer neurofibrillary tangles: antiserum and immunohistological staining. Ann Neurol (1979) 1.39
Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol (1976) 1.38
Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest (1980) 1.35
Pseudo-Zellweger syndrome: deficiencies in several peroxisomal oxidative activities. J Pediatr (1986) 1.35
Isolation of myelin from nerve tissue. Methods Enzymol (1974) 1.35
Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease. Neurology (1970) 1.33
Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol (1968) 1.33
Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol (1976) 1.29
A case of juvenile lipidosis: electron microscopic, histochemical and biochemical studies. Acta Neuropathol (1968) 1.29
Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol (1979) 1.29
Structure-function relationships in the Saccharomyces cerevisiae poly(A) polymerase. Identification of a novel RNA binding site and a domain that interacts with specificity factor(s). J Biol Chem (1995) 1.29
Differential effects of maternal heroin and methadone use on birthweight. Pediatrics (1976) 1.28
Fip1 regulates the activity of Poly(A) polymerase through multiple interactions. Mol Cell Biol (2001) 1.27
Mother rats interact differently with male and female offspring. J Comp Physiol Psychol (1979) 1.26
Ultrastructure of thalamic neuronal inclusions in myotonic dystrophy. J Neurol Sci (1975) 1.26
Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol (1973) 1.26
Breast feeding and serum bilirubin values during the first 4 days of life. J Pediatr (1973) 1.26
Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann Neurol (1979) 1.25
Autistic and dysphasic children. II: Epilepsy. Pediatrics (1991) 1.25
Hemoglobin uptake by rat hepatocytes and its breakdown within lysosomes. J Cell Biol (1970) 1.25
The intracellular release of lysosomal contents in macrophages that have ingested silica. J Histochem Cytochem (1970) 1.25
Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol (1966) 1.24
Quaking mouse: isolation and characterization of myelin protein. J Neurochem (1971) 1.22
Subgroups of children with autism by cluster analysis: a longitudinal examination. J Am Acad Child Adolesc Psychiatry (2000) 1.20
Peroxisomes (microbodies) in cell pathology. Int Rev Exp Pathol (1984) 1.20
DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells. J Invest Dermatol (1996) 1.20
Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J Neurochem (1982) 1.19
Studies on brain biopsies of patients with Huntington's chorea. J Neuropathol Exp Neurol (1974) 1.18
The significance of variations in the distribution of copper in liver disease. Am J Pathol (1980) 1.17